Monitor for actual sales in upcoming days; while this is a routine disposition, the size (~80k of which are from RSU vesting) and officer status may signal moderate liquidity needs. No immediate red flags, but watch for additional insider activity or news ahead of earnings.
Price Chart
Executive Summary
Todd DuChene, an officer of Core Scientific, filed a Form 144 to propose the sale of up to 140,000 shares, valued at approximately $2.09 million based on current market prices. The shares were acquired through the vesting of restricted stock units from June 2022 to August 2024.
Key Facts
- Reporting owner: Todd DuChene, officer of Core Scientific
- Number of shares proposed for sale: 140,000
- Approximate value of shares: $2,094,400 (based on $14.96/share)
- Shares acquired through vesting of RSUs between 06/13/2022 and 08/15/2024
- Filing date: April 1, 2026
- Shares to be sold: Common stock
Financial Impact
Approximately $2.09 million in potential insider selling
Risk Factors
- Potential downward pressure on stock if sale is executed near-term
- Perception of lack of confidence if no supporting company news accompanies the filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003161 |
| Document: 0001950047-26-003161-index.html | 0001950047-26-003161 |
| Document: 0001950047-26-003161.txt | 0001950047-26-003161 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 21, 2026 27w ago | 8-K | — | awaiting T+20 | — | — |
Apr 1, 2026 29w ago | 144 | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers